The study benchmarks a fast LC–MS workflow based on dia-PASEF and analytical flow rates, including performance on plasma samples. The work addresses a central challenge in clinical proteomics: increasing throughput without sacrificing robustness or proteome depth, helping make large-scale and reproducible plasma profiling practical for population studies.